Implementation of Naturalistic Developmental Behavioral Intervention (NDBI) Through Coaching Caregivers of Young Autistic Children
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Apr 4, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a type of therapy called Naturalistic Developmental Behavioral Interventions (NDBIs) that help young autistic children develop better social and communication skills. The goal is to train caregivers—like parents or grandparents—on how to use these strategies with their children. To do this, caregivers will watch a series of video modules that show them the core techniques of NDBIs and will receive coaching from trained clinicians over a 10-week period. Caregivers will have weekly virtual meetings where they can discuss what they learned, practice the strategies with their child, and get personalized feedback from the clinician.
To participate, caregivers must be primary caregivers of children aged 0-5 who are diagnosed with autism, a developmental delay, or a developmental disability and should be of Korean descent. Clinicians must be certified behavior analysts with experience working with young children. This trial aims to improve caregivers' confidence in implementing these strategies and to see how the child's communication skills improve. Interviews will also be conducted to better understand participants' experiences and feelings about the program. If you're interested in helping your child grow and learn in a supportive environment, this study might be a great opportunity!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Caregivers: Primary caregivers of young children aged 0-5 who meet one of the following conditions: (1) diagnosed with autism spectrum disorder, (2) diagnosed with developmental delay, and (3) diagnosed with a developmental disability. Eligible caregivers include: (1) parents, (2) grandparents, (3) legal guardians. All caregivers must be at least 18 years old and must be of Korean descent.
- • 2. Clinicians: The clinicians must hold a current Board Certified Behavior Analyst (BCBA) certification and must have experience delivering behavioral intervention and caregiver training for children aged 0-5.
- • 3. Children: Children in this study must be between 0-5 years old and must have a formal medical diagnosis confirming one of the following conditions: (1) autism spectrum disorder (ASD), (2) developmental delay, or (3) developmental disability.
- Exclusion Criteria:
- • 1. Caregivers: Caregivers will be excluded if they (1) primarily care for children over the age of 6, (2) are not Korean speakers, or (3) are unable to fully participate in study activities, such as watching training videos, recording parent-child interactions, or completing required questionnaires.
- • 2. Clinicians: Clinicians will be excluded if they (1) do not hold a valid Board Certified Behavior Analyst (BCBA) certification, (2) lack experience in providing behavioral intervention and caregiver training for children aged 0-5, or (3) only work with children over the age of 6.
- • 3. Children: Children will be excluded if they (1) are older than 5 years, (2) do not have a formal medical diagnosis confirming autism spectrum disorder, developmental delay, or developmental disability.
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported